| Old Articles: <Older 681-690 Newer> |
 |
InternetNews February 1, 2005 Sean Michael Kerner |
Nokia Launches Python Toolkit The manufacturer released an open source toolkit for its Series 60 platform, and that makes Python's creator a happy man.  |
The Motley Fool February 1, 2005 Stephen D. Simpson |
Better Days Ahead for UPM Comments from the Finnish paper company suggest a cyclical recovery might be beginning. It is admittedly difficult to buy stocks coming out of cyclical declines, because the P/Es and other valuation metrics often look too high. UPM is no exception  |
Home Toys February 2005 Sophia Antipolis |
TEAHA Market Background Document The European Application Home Alliance aims to contribute towards specs for home system architecture that will allow the interoperability and interworking of equipment, encompassing both the home control world and that of consumer electronics.  |
The Motley Fool January 31, 2005 Stephen D. Simpson |
Ryanair Weathers the Turbulence The Irish air carrier posts better than expected earnings, but still faces challenges and high valuation.  |
The Motley Fool January 31, 2005 Dave Marino-Nachison |
Wal-Mart Bids to Expand in U.K. The massive retailer has reportedly renewed efforts to build its presence overseas.  |
BusinessWeek February 7, 2005 Jack Ewing |
The Downside Of Higher Productivity A small jump in labor productivity may inspire complacency -- and slow the push for labor reform in Europe.  |
BusinessWeek February 7, 2005 Mary Lisbeth D'Amico |
A Scramble To Splice Into German Cable Financial firms are snapping up German cable properties. But what's their real aim?  |
BusinessWeek February 7, 2005 Laura Cohn |
Britain: The Battle For High Street Has Begun Weakened by discounters, Britain's old-line stores may now be takeover targets. And High Street's holiday performance makes it ever more likely that 2005 will be a critical year for the grand names of Old Brittania.  |
The Motley Fool January 28, 2005 Stephen D. Simpson |
An Understated Scandinavian The Danish pharmaceutical may not be quite cheap enough to be a true value, but investors looking for a solid growth stock should see what's new with Novo Nordisk.  |
The Motley Fool January 27, 2005 Stephen D. Simpson |
AstraZeneca Shines, for Now The British-Swedish drug company has a great quarter, but the future looks dimmer.  |
| <Older 681-690 Newer> Return to current articles. |